TCS life sciences advisory services
Embedding trusted intelligence and autonomous execution across the life sciences value chain
2
MINS READ
Industry
Life Sciences
Patient-centered Care Models Taking Center Stage in Life Sciences
Highlights
- AI-native advisory embeds intelligence into business processes, products, data, and decisions rather than adding isolated tools.
- Agentic AI orchestrates goal-driven, multi-step work across scientific, clinical, regulatory, quality, manufacturing, supply chain, and commercial functions.
- Responsible-by-design controls — including human oversight, model credibility, security, traceability, and GxP-aligned validation enable trusted adoption at scale.
Overview
Life sciences companies are moving from AI experimentation to enterprise transformation. Scientific evidence, regulatory intelligence, operational data, and frontline knowledge can now be connected through domain-aware AI to accelerate the journey from insight to decision and from decision to controlled action.
Our AI-native advisory approach helps organisations redesign work around copilots, specialised agents, and governed agent networks — while retaining accountable human decision-making for patient safety, product quality, and regulatory compliance.
Challenge
Many organisations face fragmented data, disconnected pilots, limited reuse of validated knowledge, and uncertainty about model risk, accountability, privacy, intellectual property, and regulatory expectations.
Scaling AI in a regulated environment requires more than technology - it demands a clear value agenda, fit-for-purpose data foundations, redesigned controls, workforce adoption, and lifecycle governance aligned to each AI model’s context of use.
Our solution
Our advisory services span the entire life sciences value chain and are organised around five core services:
1. Strategy and value office
- Prioritise value: Identify high-impact domain use cases, establish outcome baselines, and shape investment roadmaps.
- Scale the portfolio: Govern initiatives from pilot to enterprise deployment using measurable value, adoption, and risk indicators.
- Transform domain work: Apply research and clinical, regulatory and CMC, quality and compliance, manufacturing and laboratory, supply chain and supplier, and medical and commercial intelligence to shorten cycle times and improve decisions.
2. AI-native value chain operating model and adoption
- Redesign work: Define human–AI collaboration across copilots, specialised agents, and governed agent networks.
- Build adoption: Establish roles, decision rights, talent, training, service management, and new ways of working.
- Embed intelligence: Connect scientific, clinical, regulatory, quality, manufacturing, supply chain, and commercial processes to move from insight to controlled action.
3. Agentic architecture and engineering
- Engineer reusable capabilities: Design domain agents, knowledge graphs, retrieval patterns, tool integrations, and interoperable services.
- Orchestrate securely: Enable observable, human-in-the-loop workflows that coordinate goal-driven, multi-step execution.
- Accelerate reuse: Create modular patterns that can scale across functions, products, sites, and geographies.
4. Responsible AI and validation
- Establish trust: Apply risk classification, context-of-use assessment, model credibility, security, privacy, and human oversight.
- Validate for regulated use: Define testing, traceability, audit trails, GxP-aligned validation, and change control.
- Sustain performance: Monitor models, controls, and outcomes throughout the lifecycle to support accountable adoption at scale.
5. Business transformation services – Converting strategic priorities into executable transformation programs through target operating model design, end-to-end process redesign, digital capability roadmaps, organisational change, benefits tracking, and value realisation.
Benefits
Creating an intelligence-to-action enterprise with measurable, governed outcomes across the product lifecycle.
Key benefits include:
- Faster conversion of scientific, operational, and regulatory data into traceable decisions
- Shorter cycle times for evidence review, content generation, investigations, submissions, and operational response
- Improved quality and consistency through context-aware assistance, embedded controls, and reusable knowledge
- Greater workforce capacity by automating repetitive coordination while preserving expert review and accountability
- Earlier identification of clinical, quality, compliance, manufacturing, and supply risks
- Scalable reuse of validated AI capabilities across functions, products, sites, and geographies
- Transparent value realisation through use-case KPIs, adoption measures, and continuous model-performance monitoring